Brought to you by 
PregLem SA closes its CHF32mm Series A venture round
12 Jul 2007
Executive Summary
Concurrent with the signing of an alliance with Ipsen, PregLem SA (gynecology therapeutics) has closed its CHF32mm ($26mm) Series A venture round. Lead investor Sofinnova Partners was joined by fellow backers NeoMed Management and MVM Life Science Partners.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com